|
|
Volumn 12, Issue 1, 2013, Pages 14-15
|
|
Patent watch
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALEMTUZUMAB;
AMLODIPINE BESYLATE;
ARIPIPRAZOLE;
ATORVASTATIN;
ATYPICAL ANTIPSYCHOTIC AGENT;
BETA1A INTERFERON;
BUDESONIDE PLUS FORMOTEROL;
CELECOXIB;
CLOPIDOGREL;
DULOXETINE;
ESOMEPRAZOLE;
EXENDIN 4;
GENERIC DRUG;
IMATINIB;
INSULIN LISPRO;
METRELEPTIN;
OLANZAPINE;
OMEPRAZOLE;
PALIPERIDONE;
PRAMLINTIDE;
PRESCRIPTION DRUG;
QUETIAPINE;
RALOXIFENE;
RECOMBINANT ERYTHROPOIETIN;
RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;
RITUXIMAB;
SOFOSBUVIR;
TOCILIZUMAB;
UNINDEXED DRUG;
ZIPRASIDONE;
ARTICLE;
BIPOLAR DISORDER;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR EVENT;
DIABETES MELLITUS;
DRUG COST;
DRUG MANUFACTURE;
DRUG MARKETING;
DYSLIPIDEMIA;
HEPATITIS C;
HUMAN;
HYPERCHOLESTEROLEMIA;
MULTIPLE SCLEROSIS;
PATENT;
PRIORITY JOURNAL;
SCHIZOPHRENIA;
UNITED STATES;
DRUG INDUSTRY;
DRUGS, GENERIC;
HUMANS;
PATENTS AS TOPIC;
PHARMACEUTICAL PREPARATIONS;
UNITED STATES;
|
|
EID: 84871856351
PISSN: 14741776
EISSN: 14741784
Source Type: Journal
DOI: 10.1038/nrd3924 Document Type: Article |
|
Times cited : (13)
|
|
References (4)
|
